↓ Skip to main content

Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradication

Overview of attention for article published in Journal for Immunotherapy of Cancer, December 2018
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
8 X users
patent
2 patents

Citations

dimensions_citation
54 Dimensions

Readers on

mendeley
65 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Novel TLR2-binding adjuvant induces enhanced T cell responses and tumor eradication
Published in
Journal for Immunotherapy of Cancer, December 2018
DOI 10.1186/s40425-018-0455-2
Pubmed ID
Authors

Gijs G. Zom, Marian M. J. H. P. Willems, Selina Khan, Tetje C. van der Sluis, Jan Willem Kleinovink, Marcel G. M. Camps, Gijsbert A. van der Marel, Dmitri V. Filippov, Cornelis J. M. Melief, Ferry Ossendorp

X Demographics

X Demographics

The data shown below were collected from the profiles of 8 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 65 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 15 23%
Student > Ph. D. Student 13 20%
Student > Master 5 8%
Student > Bachelor 4 6%
Student > Doctoral Student 2 3%
Other 4 6%
Unknown 22 34%
Readers by discipline Count As %
Immunology and Microbiology 15 23%
Agricultural and Biological Sciences 8 12%
Medicine and Dentistry 6 9%
Pharmacology, Toxicology and Pharmaceutical Science 5 8%
Chemistry 5 8%
Other 3 5%
Unknown 23 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 10. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 June 2021.
All research outputs
#3,623,572
of 25,385,509 outputs
Outputs from Journal for Immunotherapy of Cancer
#996
of 3,424 outputs
Outputs of similar age
#78,139
of 444,728 outputs
Outputs of similar age from Journal for Immunotherapy of Cancer
#32
of 64 outputs
Altmetric has tracked 25,385,509 research outputs across all sources so far. Compared to these this one has done well and is in the 85th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,424 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 15.4. This one has gotten more attention than average, scoring higher than 70% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 444,728 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 64 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 50% of its contemporaries.